Covina, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Cancer Cachexia is a complex syndrome characterized by severe weight loss, muscle wasting, and significant loss of appetite in cancer patients. Unlike simple malnutrition, cancer cachexia involves a multifaceted interplay of metabolic changes that contribute to a decline in nutritional status and physical function.
Chronic inflammation is a central feature of cancer cachexia. Tumors release cytokines and other inflammatory mediators that disrupt normal metabolism, leading to muscle and fat tissue breakdown. The Cancer Cachexia Market is characterized by rapid growth, technological innovation, and fierce competition.
Companies are expanding their global presence, focusing on sustainability, and diversifying their service offerings to stay competitive. The increasing prevalence of cancer globally is a major driver for the cancer cachexia market. As the number of cancer diagnoses rises, so does the incidence of cachexia, which affects a significant proportion of cancer patients, particularly those with advanced-stage disease.
The target market is emerging as a significant area of focus within the oncology and healthcare sectors, driven by the growing recognition of cachexia as a serious and prevalent condition affecting cancer patients. Cancer Cachexia Market is segmented based on Product, Mechanism of Action, Distributional Channel, and Region. Browse Detail Report on with complete TOC @ is a specialized market research, analytics, mark.